NCT00399763View on ClinicalTrials.gov

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Attention Deficit Hyperactivity DisorderSubstance Abuse
Interventions
DRUG

Atomoxetine

Half of participants are randomized to atomoxetine plus individual cognitive behavioral therapy targeting substance use disorder

DRUG

Placebo

Half of participants are randomized to placebo plus individual cognitive behavioral therapy targeting substance use disorder

Trial Locations (1)

80204

Denver Health Medical Center, Denver

All Listed Sponsors
collaborator

American Academy of Child Adolescent Psychiatry.

OTHER

lead

Denver Health and Hospital Authority

OTHER

NCT00399763 - Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder | Biotech Hunter | Biotech Hunter